Journal
HAEMATOLOGICA
Volume 92, Issue 2, Pages 271-272Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.10737
Keywords
T-cell lymphoma; PTCL; gemcitabine; cisplatin; methylprednisolone; GEM-P
Categories
Ask authors/readers for more resources
Novel, effective therapies are needed for peripheral T-cell non-Hodgkin's lymphoma (PTCL). We treated 16 patients with a combination of gemcitabine, cisplatin and methylprednisolone (GEM-P). Three patients (19%) achieved a complete remission and eight (50%) a partial remission. GEM-P has encouraging efficacy with an acceptable toxicity profile in patients with PTCL.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available